Published: July 1, 2021

Vitamin Retailer

In a comprehensive panel discussion, industry leaders from various natural health organizations and companies delved into the pressing challenges and controversies currently facing the dietary supplement industry. A key concern highlighted was the FDA's increasingly aggressive stance on long-standing dietary supplements, with a particular focus on the retroactive status removal of supplements like NAC (N-Acetyl Cysteine). This trend raises significant questions about the agency's methodologies and the broader implications for the industry.


Read Full Article Here